Growth Metrics

Immuron (IMRN) Accumulated Expenses (2016 - 2025)

Immuron's quarterly Accumulated Expenses came in at $315639.4 in Q2 2025, down 8.35% year-on-year from $344387.1 in Q2 2024, and down 8.35% quarter-over-quarter from $344387.1 in Q2 2024.

Immuron has reported Accumulated Expenses for 10 years, with the latest figure at $315639.4 in Q2 2025.

  • For the quarter ending Q2 2025, Accumulated Expenses fell 8.35% year-over-year to $315639.4; the trailing twelve-month figure through Jun 2025 stood at $315639.4 (down 8.35% YoY), and the FY2025 full-year result was $319432.5, down 6.8% from the prior year.
  • Accumulated Expenses for Q2 2025 stood at $315639.4, down from $344387.1 in the prior quarter.
  • The five-year high for Accumulated Expenses was $344387.1 in Q2 2024, with the low at $959.31 in Q2 2022.
  • Average Accumulated Expenses over 5 years is $142684.3, with a median of $110950.4 recorded in 2021.
  • Year-over-year, Accumulated Expenses plunged 98.46% in 2021 and surged 20063.33% in 2023.
  • Tracing IMRN's Accumulated Expenses over 5 years: stood at $155188.1 in 2021, then tumbled by 59.39% to $63028.8 in 2022, then surged by 206.89% to $193428.9 in 2023, then soared by 78.04% to $344387.1 in 2024, then dropped by 8.35% to $315639.4 in 2025.
  • The last three Accumulated Expenses figures came in at $315639.4 (Q2 2025), $344387.1 (Q2 2024), and $193428.9 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Immuron 1.27 Bn 1.27 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 315,639.43
Jun 30, 2024 344,387.08
Jun 30, 2023 193,428.86
Dec 31, 2022 63,028.76
Aug 31, 2022 66,712.61
Jun 30, 2022 959.31
Dec 31, 2021 155,188.14
Jun 30, 2021 2,130.24
Jun 30, 2020 138,119.41
Jun 30, 2019 249,245.55
Dec 31, 2018 -89,391.00
Sep 27, 2018 -217,810.78
Aug 30, 2018 -297,606.00
Jun 30, 2018 329,523.03
Dec 31, 2017 -215,518.61
Sep 28, 2017 -218,106.97
Aug 31, 2017 -276,539.00
Jun 30, 2017 427,429.66
Dec 31, 2016 -84,787.09
Jun 30, 2016 -311,262.15